Literature DB >> 27756772

Silencer-of-Death Domain Mediates Acid-Induced Decrease in Cell Apoptosis in Barrett's Associated Esophageal Adenocarcinoma Cells.

Dan Li1, Jie Hong1, Weibiao Cao2.   

Abstract

We have shown that NADPH oxidase (NOX)5-S may mediate the acid-induced decrease in cell apoptosis. However, mechanisms of NOX5-S-dependent decrease in cell apoptosis are not fully understood. In this study, we found that silencer-of-death domain (SODD) was significantly increased in esophageal adenocarcinoma (EA) tissues, EA cell lines FLO and OE33, and a dysplastic cell line CP-B. Strong SODD immunostaining was significantly higher in low-grade dysplasia (66.7%), high-grade dysplasia (81.2%), and EA (71.2%) than in Barrett's mucosa (10.5%). Acid treatment significantly increased SODD protein and mRNA expression and promoter activity in FLO cells, an increase that was significantly decreased by the knockdown of NOX5-S and nuclear factor κB (NF-κB)1 p50 with their small interfering RNAs. Similarly, acid-induced increase of SODD mRNA was blocked by knockdown of NOX5-S and p50 in a BE cell line CP-A. Overexpression of NOX5-S significantly increased SODD protein expression in FLO cells. Moreover, overexpression of NOX5-S or p50 significantly increased the SODD promoter activity and decreased the caspase 9 activity or apoptosis. NOX5-S overexpression-induced increase in SODD promoter activity was significantly decreased by knockdown of p50. In addition, acid treatment significantly decreased the caspase 9 activity, a decrease that was significantly inhibited by knockdown of SODD. Furthermore, chromatin immunoprecipitation assay showed that NF-κB1 p50 bound to SODD genomic DNA containing a NF-κB-binding element GGGGACACCCT. This binding element was further confirmed by a gel mobility shift assay. We conclude that acid-induced increase in SODD expression and decrease in cell apoptosis may depend on the activation of NOX5-S and NF-κB1 p50 in FLO cells.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27756772      PMCID: PMC5193081          DOI: 10.1124/jpet.116.236620

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  28 in total

1.  Role of NADPH oxidase NOX5-S, NF-κB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells.

Authors:  Jie Hong; Dan Li; Jack Wands; Rhonda Souza; Weibiao Cao
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-11       Impact factor: 4.249

2.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1.

Authors:  B Bánfi; A Maturana; S Jaconi; S Arnaudeau; T Laforge; B Sinha; E Ligeti; N Demaurex; K H Krause
Journal:  Science       Date:  2000-01-07       Impact factor: 47.728

4.  Enhanced expression of Silencer of death domains (SODD/BAG-4) in pancreatic cancer.

Authors:  F Ozawa; H Friess; A Zimmermann; J Kleeff; M W Büchler
Journal:  Biochem Biophys Res Commun       Date:  2000-05-10       Impact factor: 3.575

Review 5.  A single NFκB system for both canonical and non-canonical signaling.

Authors:  Vincent Feng-Sheng Shih; Rachel Tsui; Andrew Caldwell; Alexander Hoffmann
Journal:  Cell Res       Date:  2010-11-23       Impact factor: 25.617

6.  Cell transformation by the superoxide-generating oxidase Mox1.

Authors:  Y A Suh; R S Arnold; B Lassegue; J Shi; X Xu; D Sorescu; A B Chung; K K Griendling; J D Lambeth
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

7.  Risk factors in the development of esophageal adenocarcinoma.

Authors:  Heiko Pohl; Katharina Wrobel; Christian Bojarski; Winfried Voderholzer; Amnon Sonnenberg; Thomas Rösch; Daniel C Baumgart
Journal:  Am J Gastroenterol       Date:  2012-12-18       Impact factor: 10.864

8.  Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.

Authors:  Hashem B El-Serag; Thomas V Aguirre; Stephanie Davis; Mark Kuebeler; Achyut Bhattacharyya; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2004-10       Impact factor: 10.864

9.  An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators.

Authors:  S Takayama; Z Xie; J C Reed
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

10.  Prevention of constitutive TNF receptor 1 signaling by silencer of death domains.

Authors:  Y Jiang; J D Woronicz; W Liu; D V Goeddel
Journal:  Science       Date:  1999-01-22       Impact factor: 47.728

View more
  1 in total

1.  Inhibiting the Activity of NADPH Oxidase in Cancer.

Authors:  Mariam M Konaté; Smitha Antony; James H Doroshow
Journal:  Antioxid Redox Signal       Date:  2020-04-17       Impact factor: 8.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.